Summary
CVS Health Corporation (CVS) filed an 8-K on November 6, 2019, primarily to report its financial results for the third quarter ended September 30, 2019. The report itself is brief, furnishing a press release (Exhibit 99.1) that contains the detailed operational and financial information. Investors should refer to this press release for specifics on revenue, earnings, and any forward-looking guidance provided by the company for the period. This filing serves as the official mechanism to make these results publicly available in accordance with SEC regulations.
Key Highlights
- 1CVS Health filed an 8-K on November 6, 2019, to announce Q3 2019 financial results.
- 2The 8-K report incorporates by reference a press release dated November 6, 2019 (Exhibit 99.1) containing the detailed financial results.
- 3Investors are directed to the furnished press release for specific performance metrics, including revenue and earnings.
- 4The information furnished in this 8-K is not considered 'filed' for certain SEC liability purposes.
- 5This filing ensures timely public disclosure of CVS Health's quarterly financial performance.
Frequently Asked Questions
The primary purpose of this 8-K filing by CVS Health Corporation is to officially report its financial results for the third quarter ended September 30, 2019, to the public and the SEC.
The detailed financial results and operational performance for the three months ended September 30, 2019, are contained within the press release furnished as Exhibit 99.1 to this 8-K filing.
While the 8-K itself does not contain the detailed guidance, the accompanying press release (Exhibit 99.1) typically includes the company's forward-looking statements and financial outlook, which investors should review.
No, the information furnished in this Current Report on Form 8-K is explicitly stated as not being deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it subject to the liabilities of that section.